Ugro Capital
- Market cap
- ₹ 1,166 Cr.
- P/E
- 6.7x
- P/B
- 0.41x
- 52-week range
- 72.11 – 189.92
- ROE
- 5%
- Dividend yield
- 0%
- Debt / equity
- 3.74
- Sector
- Finance
- Industry
- Non Banking Financial Company (NBFC)
- Listed on
- NSE, BSE
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Non Banking Financial Company (NBFC): 288 companies →Ugro Capital against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)6.7 against a typical 22.5: cheaper than most peers (1st = cheapest).38th of 284
- Sales growth+0.7% against a typical +18.3% from a year earlier.175th of 259
- Profit growth+79.4% against a typical +20.2% from a year earlier.56th of 214
- Share price, 3 months−22.8% against a typical −4.2%.227th of 258
- Size₹ 1,165.9 Cr. market value against a typical ₹ 43 Cr. (1st = largest).31st of 269
Latest announcements
Exchange filings and their impact on the company.
- NCLT sets 20 Nov 2026 final hearing for UGRO-Profectus merger; no completion yet.
UGRO Capital said its scheme of amalgamation with Profectus Capital Private Limited was admitted by NCLT Mumbai on 9th October 2026. The final hearing is scheduled for 20th November 2026. The merger is not yet approved or completed, so there is no immediate financial impact.
- UGRO allotted USD 10m (~Rs 88 cr) dollar NCDs, a tiny add to its Rs 9,208 cr debt.
UGRO Capital allotted 1,000 senior unsecured USD-denominated redeemable non-convertible bonds of USD 10,000 each, totalling USD 10 million via private placement on 9 Oct 2026. At current FX rates this is about Rs 88 crore. For an NBFC with Rs 9,208 crore of borrowings, this is a small incremental funding line for onward lending.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Look closer
Rated A+ by India Ratings- CARE lowered its rating on 19 Nov 2025.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | Withdrawn | — | 15 Oct 2026 |
| Acuite | — | — | 4 Aug 2026 |
| CRISIL | Withdrawn | Stable | 17 Dec 2025 |
| India Ratings | IND A+ | Positive | 17 Dec 2025 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 15 Oct 2026 | Withdrawn | — | — | CARE | — | |
| 4 Aug 2026 | Rating action | — | — | Acuite | ₹ 800 Cr. | |
| 27 Jan 2026 | Reaffirmed | ACUITE A | — | Acuite | ₹ 26 Cr. | |
| 12 Jan 2026 | ▲ Upgrade1 notch | CARE A+ (SO) → CARE AA- (SO) | — | CARE | ₹ 25.15 Cr. | |
| 17 Dec 2025 | Withdrawn | was Crisil A | — | CRISIL | ₹ 814.28 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 5 Nov 2026Upcoming | Financial Results/Other business matters | To consider and approve the Unaudited Financial Results Standalone and Consolidated for the quarter and half year ended 30th September 2026 along with the Limited Review Report and to consider any other items with the permission of the Chair. |
| 4 Aug 2026 | Financial Results/Other business matters | Intimation of the meeting of the Board of Directors scheduled to be held on Tuesday, 04th August 2026 |
| 20 Apr 2026 | Financial Results/Fund Raising/Other business matters | To consider and approve the audited financial statements (standalone and consolidated) for the quarter and year ended March 31, 2026, Fund Raising and other business matters |
| 7 Feb 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2025 and other business matters |
| 8 Jan 2026 | Fund Raising/Other business matters | Intimation of Board Meeting scheduled to be held on 08th January 2026 |
| 7 Nov 2025 | Financial Results | To consider and approve the Unaudited financial results for the quarter and half year ended September 30, 2025 |
| 11 Aug 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 245 | 268 | 322 | 291 | 330 | 371 | 403 | 414 | 455 | 409 | 488 | 417 |
| Interest | 105 | 117 | 128 | 136 | 143 | 167 | 181 | 205 | 219 | 237 | 242 | 248 |
| Expenses | 99 | 107 | 136 | 113 | 139 | 152 | 161 | 156 | 167 | 188 | 198 | 147 |
| Financing Profit | 41 | 44 | 58 | 43 | 48 | 52 | 61 | 53 | 69 | −16 | 48 | 22 |
| Financing Margin % | 17% | 16% | 18% | 15% | 15% | 14% | 15% | 13% | 15% | −4% | 10% | 5% |
| Other Income | 9 | 12 | 8 | 10 | 13 | 14 | 9 | 8 | 6 | 39 | 21 | 37 |
| Depreciation | 9 | 9 | 10 | 10 | 11 | 12 | 13 | 13 | 14 | 14 | 27 | 10 |
| Profit before tax | 41 | 46 | 56 | 43 | 50 | 53 | 57 | 48 | 61 | 10 | 42 | 49 |
| Tax % | 29% | 30% | 42% | 29% | 29% | 29% | 29% | 29% | 29% | 34% | 29% | −25% |
| Net Profit | 29 | 33 | 33 | 30 | 36 | 38 | 41 | 34 | 43 | 6 | 30 | 61 |
| EPS in Rs | 2.47 | 2.78 | 2.78 | 2.58 | 3.02 | 3.18 | 3.44 | 2.92 | 3.71 | 0.41 | 1.9 | 3.91 |
| Gross NPA % | 1.9% | 2% | 2% | 2% | 2.1% | 2.1% | 2.3% | 2.5% | 2.4% | 2.2% | 2.5% | 2.6% |
| Net NPA % | 1.1% | 1.1% | 1.1% | 1.2% | 1.3% | 1.5% | 1.6% | 1.7% | 1.5% | 1.4% | 1.6% | 1.9% |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 85%
- 5 Years
- 63%
- 3 Years
- 38%
- TTM
- 17%
- 10 Years
- 44%
- 5 Years
- 32%
- 3 Years
- 42%
- TTM
- −5%
- 10 Years
- 12%
- 5 Years
- −7%
- 3 Years
- −34%
- TTM
- —
- 10 Years
- 5%
- 5 Years
- 6%
- 3 Years
- 7%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Prices are delayed and for information only. Nothing on this page is investment advice.